PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
8.36%
Revenue growth below 50% of CRWV's 23.55%. Michael Burry would check for competitive disadvantage risks.
3.88%
Cost growth less than half of CRWV's 19.16%. David Dodd would verify if cost advantage is structural.
9.31%
Gross profit growth below 50% of CRWV's 25.15%. Michael Burry would check for structural issues.
0.87%
Margin expansion 50-75% of CRWV's 1.30%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
13.16%
Operating expenses growth 50-75% of CRWV's 17.97%. Bruce Berkowitz would examine efficiency.
10.71%
Total costs growth 50-75% of CRWV's 18.28%. Bruce Berkowitz would examine efficiency.
No Data
No Data available this quarter, please select a different quarter.
15.00%
D&A growth 50-75% of CRWV's 26.15%. Bruce Berkowitz would examine asset strategy.
4.98%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
-5.29%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
3.85%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
-4.16%
Operating margin decline while CRWV shows 156.60% growth. Joel Greenblatt would examine position.
69.05%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
6.33%
Pre-tax income growth 50-75% of CRWV's 9.63%. Martin Whitman would scrutinize operations.
-1.88%
Pre-tax margin decline while CRWV shows 26.86% growth. Joel Greenblatt would examine position.
6.21%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
6.38%
Similar net income growth to CRWV's 7.67%. Walter Schloss would investigate industry trends.
-1.83%
Net margin decline while CRWV shows 25.27% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.44%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
6.44%
Diluted share reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.